Dexmedetomidine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dexmedetomidine Hydrochloride Injection (injection) from Amneal Pharmaceuticals with status Current. The shortage was first posted on 04/10/2020.
Shortage Details
- Status
- Current
- Company
- Amneal Pharmaceuticals
- Package NDC
- 70121-1389-1
- Dosage Form
- Injection
- Presentation
- Dexmedetomidine Hydrochloride, Injection, 4 mcg/mL, 100 mL (NDC 70121-1389-1)
- Initial Posting
- 04/10/2020
- Revised Date